[Intravenous or subcutaneous heparin. What is better in deep venous thrombosis?].
D001682:Biological Availability; D002986:Clinical Trials as Topic; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy*
D006495:Heparin, Low-Molecular-Weight; C094240:reviparin; D006493:Heparin